Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 7/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | REN | P00797 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PEPD | P12955 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL351762 | 1.00 | CYP1A2 (0.40) | CYP1A2ACECYP2C19RENLMNA | |
| SCHEMBL15665285 | 1.00 | CYP1A2 (0.40) | CYP1A2ACECYP2C19RENLMNA | |
| Hydrochloric Acid SCHEMBL9734098 | 0.98 | CYP1A2 (0.40) | CYP1A2ACECYP2C19RENLMNA | |
| Hydrochloric Acid SCHEMBL19510378 | 0.98 | CYP1A2 (0.40) | CYP1A2ACECYP2C19RENLMNA | |
| SCHEMBL31053890 | 0.98 | CYP1A2 (0.40) | CYP1A2ACECYP2C19RENLMNA | |
| SCHEMBL5531122 | 0.95 | SMN1; SMN2 (0.43) | CYP1A2ACECYP2C19SMN1; SMN2 | |
| SCHEMBL5898651 | 0.93 | SMN1; SMN2 (0.42) | CYP1A2ACECYP2C19SMN1; SMN2 | |
| SCHEMBL5898685 | 0.89 | ACE (0.37) | ACE | |
| SCHEMBL5701867 | 0.89 | ACE (0.37) | ACE | |
| SCHEMBL5701885 | 0.89 | ACE (0.37) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112174870-A | Preparation method and medicinal application of (R) -1-alkanoyl-2-substituted pyrrolidine-2-formamide | 蔡霈 | 2021-01-05 | — | — | CN | claimed |
| EP-3239123-B1 | METHOD OF PREPARING DIFLUORINATED ALCOHOL COMPOUND | SAMHWA PAINTS IND CO LTD (KR) | 2020-01-29 | — | — | EP | claimed |
| US-10329341-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-06-25 | — | — | US | claimed |
| US-20180030115-A1 | COLLAGEN MIMICS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-01 | — | — | US | claimed |
| EP-2760881-B1 | NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS | NOSOPHARM (FR) | 2017-11-01 | — | — | EP | claimed |
| US-9758569-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-09-12 | — | — | US | claimed |
| US-9260481-B2 | Peptide derivatives as antibiotics | NOSOPHARM (FR) | 2016-02-16 | — | — | US | claimed |
| US-20150353619-A1 | Non-Canonical Insulins and Their Uses | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2015-12-10 | — | — | US | claimed |
| US-20150175659-A1 | Peptide Derivatives as Antibiotics | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2015-06-25 | — | — | US | claimed |
| EP-2760881-A1 | NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS | Nosopharm (FR) | 2014-08-06 | — | — | EP | claimed |
| WO-2013045600-A1 | NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS | NOSOPHARM (FR) | 2013-04-04 | — | — | WO | claimed |
| US-20100016545-A1 | PROCESS FOR THE COVALENT COUPLING OF TWO MOLECULES BY MEANS OF A DIELS-ALDER REACTION WITH INVERSE ELECTRON REQUIREMENT | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2010-01-21 | — | — | US | claimed |
| WO-2007139914-A2 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | claimed |
| US-20070275897-A1 | Collagen mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-11-29 | — | — | US | claimed |
| US-20060136023-A1 | Method and apparatus for patient temperature control employing administration of anti-shivering agents | MARVIN, ROBERT | 2006-06-22 | — | — | US | claimed |
| US-6869440-B2 | Method and apparatus for patient temperature control employing administration of anti-shivering agents | INNERCOOL THERAPIES, INC. (US) | 2005-03-22 | — | — | US | claimed |
| US-20030060863-A1 | Method and apparatus for patient temperature control employing administration of anti-shivering agents | ZOLL CIRCULATION, INC. | 2003-03-27 | — | — | US | claimed |
| WO-2003015672-A1 | METHOD AND APPARATUS FOR PATIENT TEMPERATURE CONTROL EMPLOYING ADMINISTRATION OF ANTI-SHIVERING | INNERCOOL THERAPIES, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| CN-122055379-A | Compounds containing one or more diboronate esters and related insulin analogues | 普罗托莫科技公司 | 2026-05-15 | — | — | CN | disclosed |
| US-4284624-A | HYPOTENSIVE PEPTIDES | E. R. SQUIBB & SONS, INC. (US) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016545-A1 | PROCESS FOR THE COVALENT COUPLING OF TWO MOLECULES BY MEANS OF A DIELS-ALDER REACTION WITH INVERSE ELECTRON REQUIREMENT | CX3CR1, NR3C2, NR4A2 | CYP1A2 917/4885ACE 4286/4885CYP2C19 3510/4885 |
| US-20150353619-A1 | Non-Canonical Insulins and Their Uses | IAPP, IDE, INSR | CYP1A2 2895/4885ACE 164/4885CYP2C19 258/4885 |
| US-20150175659-A1 | Peptide Derivatives as Antibiotics | VIP, NGLY1, NRDC | CYP1A2 4521/4885ACE 70/4885CYP2C19 3537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.